MedNanoTech

  • Skip to content
  • Jump to main navigation and login

Nav view search

Navigation

  • Home
  • About Us
  • Research
  • Applications
  • Services
  • Contact Us

Search

You are here: Home

Latest News is closed

See at us MedVentures 2011

MedNanoTech chosen as a Quick Pitch company for the upcoming NTEC MedVentures 2011 Conference on October 6th in Frisco, Texas.

 

Welcome to Medical Nanotechnologies

Medical Nanotechnologies, Inc. (MedNanoTech) is an emerging nanotechnology company focused on bringing carbon nanoparticle-based products to market through developing techniques that will enable the production of high-quality, application-specific carbon nanoparticles (CNPs).

We continue to expand our repertoire of methods to conjugate carbon nanoparticles with targeting agents for medical use and to assess the purity and biological activity of carbon nanoparticles.

Expertise

MedNanoTech has expertise in the following:

  • performing nanoparticle conjugation
  • determining nanoparticle size and composition
  • evaluating toxicity of nanoparticles and nanoparticle conjugates
  • analyzing the subcellular activity of nanoparticles and their conjugates

Technology

We are developing methods to create targeted carbon nanoparticles for therapeutic, diagnostic, and research purposes. These carbon nanoparticles include:

  • Polymer nanoparticles
  • Carbon nanotubes
  • Graphene oxide nanoparticles

We are also establishing a suite of protocols that can be used to assess and remediate the purity and toxicity of carbon nanoparticles both in the work place and in finished products. These protocols include:

  • Measurement of trace contaminants within carbon nanoparticle batches
  • Assessment of cytotoxicity of as-produced carbon nanoparticles
  • Determination of the presence and quantification of carbon nanoparticles within the work environment

 

Applications

MedNanoTech is focused on developing applications that use the unique physicochemical properties of carbon nanoparticles.

Our current efforts in application development include:

  • Targeted hyperthermia for breast and other cancers
  • Nanoparticle-mediated thermal release of drug payloads
  • Development of test protocols for evaluating the toxicity of carbon nanotubes
  • Development of protocols for nanoparticle conjugates
  • The study of nanoparticle interactions with mammalian cells

Powered by Joomla!®